Article
Molecular population genetics of PCSK9: a signature of recent positive selection.
Pharmacogenetics and genomics - 1 Mar 2008
Ding Keyue, Kullo Iftikhar J
Abstract excerpt
OBJECTIVE: Proprotein convertase subtilisin-like kexin type 9 (PCSK9) is a newly discovered serine protease that plays a key role in regulating plasma low density lipoprotein (LDL) cholesterol levels. Both rare mutations and common variants in the coding regions of PCSK9 affect LDL cholesterol levels and coronary heart disease risk, as well as response to lipid-lowering therapy. METHODS: The authors characterized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
